1186600-65-6
1186600-65-6
Chemical Structure
Talogreptide vizaxetan
Synonym(s): RM2
- CAS No.: 1186600-65-6
- Formula:C78H118N20O19
- Molecular Weight:1639.89
InChIKey: FVXOTFZQNLDBMN-NXGMBKMSSA-N
SMILES: O=C(N[C@@H](CCC(N)=O)C(N[C@@H](CC1=CNC2=CC=CC=C12)C(N[C@@H](C)C(N[C@@H](C(C)C)C(NCC(N[C@@H](CC3=CNC=N3)C(N[C@@H](CC(C)C)[C@@H](O)CC(N[C@@H](CC(C)C)C(N)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](NC(CN4CCC(NC(CN5CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC5)=O)CC4)=O)CC6=CC=CC=C6
Biological Activity: RM2 is a GRPr antagonist. RM2 selectively binds to GRPr, blocks agonist-induced receptor internalization, and inhibits agonist-triggered intracellular calcium mobilization. RM2 can be used in studies related to prostate cancer[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Talogreptide vizaxetan | 98.12% | RM2 is a GRPr antagonist. RM2 selectively binds to GRPr, blocks agonist-induced receptor internalization, and inhibits agonist-triggered intracellular calcium mobilization. RM2 can be used in studies related to prostate cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
